pEVs offer promise as biomarkers [96], showing a stronger correlation with AKI severity than traditional markers like blood urea nitrogen (BUN), serum creatinine (SCr), and neutrophil gelatinase-associated lipocalin (NGAL), enabling earlier AKI detection [97]. This evidence concerns the gene LCN2 and acute kidney injury.